Despite lower B7-H3 positivity, the administration of B7H3.CAR EBVSTs effectively inhibited tumor growth in 4 of 8 mice, in contrast to the uncontrolled tumor growth seen in all untreated and UT EBVST-treated mice (Supplementary Fig. S4G). This evidence concerns the gene CD276 and neoplasm.